146 related articles for article (PubMed ID: 36608736)
1. From phosphorylation to phenotype - Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK.
Prömer J; Barresi C; Herbst R
Cell Signal; 2023 Apr; 104():110584. PubMed ID: 36608736
[TBL] [Abstract][Full Text] [Related]
2. MuSk function during health and disease.
Herbst R
Neurosci Lett; 2020 Jan; 716():134676. PubMed ID: 31811897
[TBL] [Abstract][Full Text] [Related]
3. Structure and activation of MuSK, a receptor tyrosine kinase central to neuromuscular junction formation.
Hubbard SR; Gnanasambandan K
Biochim Biophys Acta; 2013 Oct; 1834(10):2166-9. PubMed ID: 23467009
[TBL] [Abstract][Full Text] [Related]
4. LRP4 third β-propeller domain mutations cause novel congenital myasthenia by compromising agrin-mediated MuSK signaling in a position-specific manner.
Ohkawara B; Cabrera-Serrano M; Nakata T; Milone M; Asai N; Ito K; Ito M; Masuda A; Ito Y; Engel AG; Ohno K
Hum Mol Genet; 2014 Apr; 23(7):1856-68. PubMed ID: 24234652
[TBL] [Abstract][Full Text] [Related]
5. The MuSK activator agrin has a separate role essential for postnatal maintenance of neuromuscular synapses.
Tezuka T; Inoue A; Hoshi T; Weatherbee SD; Burgess RW; Ueta R; Yamanashi Y
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16556-61. PubMed ID: 25368159
[TBL] [Abstract][Full Text] [Related]
6. Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.
Maselli RA; Arredondo J; Cagney O; Ng JJ; Anderson JA; Williams C; Gerke BJ; Soliven B; Wollmann RL
Hum Mol Genet; 2010 Jun; 19(12):2370-9. PubMed ID: 20371544
[TBL] [Abstract][Full Text] [Related]
7. Dok-7 regulates neuromuscular synapse formation by recruiting Crk and Crk-L.
Hallock PT; Xu CF; Park TJ; Neubert TA; Curran T; Burden SJ
Genes Dev; 2010 Nov; 24(21):2451-61. PubMed ID: 21041412
[TBL] [Abstract][Full Text] [Related]
8. Collagen Q and anti-MuSK autoantibody competitively suppress agrin/LRP4/MuSK signaling.
Otsuka K; Ito M; Ohkawara B; Masuda A; Kawakami Y; Sahashi K; Nishida H; Mabuchi N; Takano A; Engel AG; Ohno K
Sci Rep; 2015 Sep; 5():13928. PubMed ID: 26355076
[TBL] [Abstract][Full Text] [Related]
9. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
[TBL] [Abstract][Full Text] [Related]
10. Mutations causing DOK7 congenital myasthenia ablate functional motifs in Dok-7.
Hamuro J; Higuchi O; Okada K; Ueno M; Iemura S; Natsume T; Spearman H; Beeson D; Yamanashi Y
J Biol Chem; 2008 Feb; 283(9):5518-24. PubMed ID: 18165682
[TBL] [Abstract][Full Text] [Related]
11. Lrp4 is a receptor for Agrin and forms a complex with MuSK.
Kim N; Stiegler AL; Cameron TO; Hallock PT; Gomez AM; Huang JH; Hubbard SR; Dustin ML; Burden SJ
Cell; 2008 Oct; 135(2):334-42. PubMed ID: 18848351
[TBL] [Abstract][Full Text] [Related]
12. Dok-7/MuSK signaling and a congenital myasthenic syndrome.
Yamanashi Y; Higuch O; Beeson D
Acta Myol; 2008 Jul; 27(1):25-9. PubMed ID: 19108574
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms underlying the formation of neuromuscular junction].
Higuchi O; Yamanashi Y
Brain Nerve; 2011 Jul; 63(7):649-55. PubMed ID: 21747134
[TBL] [Abstract][Full Text] [Related]
14. A mutation causes MuSK reduced sensitivity to agrin and congenital myasthenia.
Ben Ammar A; Soltanzadeh P; Bauché S; Richard P; Goillot E; Herbst R; Gaudon K; Huzé C; Schaeffer L; Yamanashi Y; Higuchi O; Taly A; Koenig J; Leroy JP; Hentati F; Najmabadi H; Kahrizi K; Ilkhani M; Fardeau M; Eymard B; Hantaï D
PLoS One; 2013; 8(1):e53826. PubMed ID: 23326516
[TBL] [Abstract][Full Text] [Related]
15. Rapsyn carboxyl terminal domains mediate muscle specific kinase-induced phosphorylation of the muscle acetylcholine receptor.
Lee Y; Rudell J; Yechikhov S; Taylor R; Swope S; Ferns M
Neuroscience; 2008 Jun; 153(4):997-1007. PubMed ID: 18436384
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex.
Xie T; Xu G; Liu Y; Quade B; Lin W; Bai XC
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2300453120. PubMed ID: 37252960
[TBL] [Abstract][Full Text] [Related]
17. LRP4 serves as a coreceptor of agrin.
Zhang B; Luo S; Wang Q; Suzuki T; Xiong WC; Mei L
Neuron; 2008 Oct; 60(2):285-97. PubMed ID: 18957220
[TBL] [Abstract][Full Text] [Related]
18. MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
Koneczny I; Cossins J; Waters P; Beeson D; Vincent A
PLoS One; 2013; 8(11):e80695. PubMed ID: 24244707
[TBL] [Abstract][Full Text] [Related]
19. Developmental consequences of the ColQ/MuSK interactions.
Karmouch J; Dobbertin A; Sigoillot S; Legay C
Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
[TBL] [Abstract][Full Text] [Related]
20. The role of MuSK in synapse formation and neuromuscular disease.
Burden SJ; Yumoto N; Zhang W
Cold Spring Harb Perspect Biol; 2013 May; 5(5):a009167. PubMed ID: 23637281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
